Olpasiran significantly reduces lipoprotein(a) levels in patients with cardiovascular disease | 2 Minute Medicine 2 Minute Medicine , 21 Nov 2022 1. Olpasiran significantly and substantially reduced lipoprotein(a) concentration in patients with atherosclerotic…